Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DR26FMDT0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,944
Award facts
- Contract value 100% obligated
- $15,944.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,944.40 for Mirena 52 mg contraceptive systems by the Defense Logistics Agency on October 22, 2025. This firm fixed-price delivery order, with an ultimate completion date of November 13, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors for the Department of Defense healthcare system.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. This IDC authorizes the Defense Logistics Agency to issue delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. As a critical pharmaceutical supplier within the federal military medical supply chain, DMS Pharmaceutical Group has demonstrated substantial performance across multiple therapeutic categories, positioning it as a key provider for the department's recurring medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FMDT0?
SPE2DR26FMDT0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FMDT0 worth?
The government has obligated $15,944 on SPE2DR26FMDT0.
Is contract SPE2DR26FMDT0 an order under another contract?
Yes. SPE2DR26FMDT0 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDT0 competed?
The extent of competition for SPE2DR26FMDT0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award